Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Sanofi

02 12care4

03 2Accord healthcare

04 2Medical Valley

05 2Mepha Pharma

06 1ORIFARM GROUP AS

07 4Pfizer Inc

08 2STADA Arzneimittel

09 2Spirig Healthcare

10 2Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Fesoterodinum

Brand Name : Fesoterodin Zentiva

Dosage Form : Modified Release Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 31/03/2022

Application Number : 68694

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Fesoterodinum

Brand Name : Fesoterodin Zentiva

Dosage Form : Modified Release Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 31/03/2022

Application Number : 68694

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine 2Care4

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 16/05/2023

Application Number : 20230222000029

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Accord

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 26/10/2022

Application Number : 20210524000033

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Accord

Dosage Form : Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 26/08/2021

Application Number : 20200330000013

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Medical Valley

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 17/07/2022

Application Number : 20200227000041

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Medical Valley

Dosage Form : Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 17/07/2022

Application Number : 20200227000058

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinum

Brand Name : Fesoterodin-Mepha

Dosage Form : Modified Release Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 27/06/2022

Application Number : 68790

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinum

Brand Name : Fesoterodin-Mepha

Dosage Form : Modified Release Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 27/06/2022

Application Number : 68790

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Zentiva

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 26/11/2024

Application Number : 20240815000046

Regulatory Info : Approved

Registration Country : Sweden

blank

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Toviaz

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 20/04/2007

Application Number : 20060315000045

Regulatory Info : Approved

Registration Country : Sweden

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Toviaz

Dosage Form : Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 20/04/2007

Application Number : 20060315000052

Regulatory Info : Approved

Registration Country : Sweden

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinum

Brand Name : Toviaz

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 18/12/2008

Application Number : 58743

Regulatory Info : Allowed

Registration Country : Switzerland

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinum

Brand Name : Toviaz

Dosage Form : Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 18/12/2008

Application Number : 58743

Regulatory Info : Allowed

Registration Country : Switzerland

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinum

Brand Name : Fesoterodin Spirig HC retard

Dosage Form : Modified Release Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 05/09/2024

Application Number : 69550

Regulatory Info : Allowed

Registration Country : Switzerland

blank

16

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinum

Brand Name : Fesoterodin Spirig HC retard

Dosage Form : Modified Release Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 05/09/2024

Application Number : 69550

Regulatory Info : Allowed

Registration Country : Switzerland

blank

17

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Stada

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 19/04/2021

Application Number : 20200327000019

Regulatory Info : Approved

Registration Country : Sweden

blank

18

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Stada

Dosage Form : Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 19/04/2021

Application Number : 20200327000026

Regulatory Info : Approved

Registration Country : Sweden

blank

19

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Zentiva

Dosage Form : Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 06/02/2023

Application Number : 20220928000010

Regulatory Info : Approved

Registration Country : Sweden

blank

20

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Fesoterodinfumarat

Brand Name : Fesoterodine Zentiva

Dosage Form : Tablet

Dosage Strength : 8mg

Packaging :

Approval Date : 06/02/2023

Application Number : 20220928000027

Regulatory Info : Approved

Registration Country : Sweden

blank